1Semana·

There seems to be some movement in the share. Is there any news that I have missed?

2
3 Comentários

phase 2b studies results preserved lean mass after glp-1
https://ir.verupharma.com/news-events/press-releases/detail/236/veru-reports-positive-results-from-phase-2b-quality-and Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation :: Veru Inc. (VERU)
Ok thanks for the information
Participar na conversa